Achucarro and UPV/EHU Gather International Experts in Plentzia to Advance Glial Cell Knowledge

The AIGS 2026 scientific meeting brings together world leaders and emerging researchers in glial neuroscience.

Generic image: Exterior of the Plentzia Marine Station (PiE) during the day, with the sea.
IA

Generic image: Exterior of the Plentzia Marine Station (PiE) during the day, with the sea.

The Plentzia Marine Station (PiE) is hosting AIGS 2026, an event by the Achucarro Basque Center for Neuroscience and the University of the Basque Country (UPV/EHU), bringing together global leaders and future talents in neuroscience.

International specialists in glial neuroscience are gathering in Plentzia to deepen the understanding of the cells that regulate brain function. AIGS 2026, now in its third edition, is a joint initiative of the Achucarro Basque Center for Neuroscience and the UPV/EHU, establishing itself as a European leader following the 2018 in-person and 2021 online editions.
This multidisciplinary and immersive symposium features keynote lectures, panel discussions, project mentoring sessions, and methodological workshops, aligning with the strategic mission to lead frontier science and position the Basque Country as an international hub for neurosciences.
The brain is not solely composed of neurons; nearly half its cells are glial. Once considered mere "support" cells, they are now known to be crucial: nourishing neurons, insulating their connections, and acting as the brain's immune system.
Alterations in neuron-glia interactions are central to numerous pathologies, including neurodevelopmental disorders, neurodegenerative diseases like Alzheimer's and Parkinson's, and psychiatric disorders. Advances in transcriptomics and microscopy have revealed unexpected functional heterogeneity, opening new therapeutic avenues.
The Achucarro center specializes in neuron-glia interaction and is a global leader in glial research, employing a longitudinal approach from development to aging across conditions such as autism, stroke, epilepsy, and neurodegenerative diseases.
This year's edition particularly focuses on glial metabolism, a highly active frontier in neuroscience, with direct implications for neurodegenerative diseases, cognitive function, and the identification of novel therapeutic targets.
Based on information from the official source: UPV/EHU — Universidad del País Vasco (Campusa) (17/09/2026)